{"id":"3acaecc8-b3b6-43b7-8a6b-a20e531c0cad","arxiv_id":"2607.04673","paper_version":1,"verdict":"CONDITIONAL","confidence":"HIGH","novelty_score":5.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":4,"one_line_summary":"A biomarker knowledge graph with 11 clinical rules is fused post hoc with ResNet50 features to yield explainable glaucoma diagnosis and risk scores, with high metrics framed as an upper bound under label-correlated annotations.","lead":"GlaKG builds a fundus knowledge graph of clinical glaucoma biomarkers and 11 diagnostic rules, then fuses it with image features so every prediction ships with an explicit reasoning chain. It is a practical bid to make automated glaucoma screening auditable by clinicians instead of a black box.","discovery_kind":"new_method","skeptic_critique":{"model":"grok-4.5","headline":"No significant objection beyond the reader's correctly identified biomarker-availability premise; the paper's own framing already treats metrics as upper bounds under clean structured inputs.","rationale":"The reader's weakest_assumption correctly isolates the availability/fidelity of structured biomarkers of the quality present in the AI-annotated JSON. That condition is required for the KG branch and the reported upper-bound metrics to transfer, is openly acknowledged in Sec. IV-B1 and Sec. VII, and is already used by the authors to frame F1=0.9953 / Acc=0.930 as non-leakage-free. Because the paper does not claim leakage-free image-only superiority, and because the reasoning-chain audit trail remains well-defined even when biomarkers are imperfect, the concern does not force a stricter verdict. No independent load-bearing flaw (e.g., end-to-end label leakage into the image classifier, unstated data-dependent thresholds, or contradiction between fusion design and reported numbers) appears after full-text inspection. Therefore the CONDITIONAL verdict stands without adjustment.","tokens_in":13627,"tokens_out":573,"duration_ms":4836,"concrete_test":"On a held-out fundus set that supplies only raw images (no AI JSON biomarkers), extract biomarkers with an independent detector, recompute chain scores via the same 11 rules, fuse at α=0.5, and check whether binary F1 remains ≥0.95 and whether low chain scores still flag the residual errors; if F1 collapses below image-only baselines or chains become uninformative, the upper-bound framing is confirmed and the deployment claim weakens.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim is that GlaKG supplies a clinically auditable reasoning framework (explicit chains from biomarkers through 11 fixed rules) that complements image features, with reported F1/accuracy framed as upper bounds under clean structured biomarkers rather than leakage-free image-only performance. The paper already isolates the KG score from training (post-processing fusion, Eq. 12; all fitting on train only; Sec. IV-B1), discloses near-perfect annotation–label separation (100% rim thinning/ISNT in glaucoma, 0% pathology in normals; Tables III, VI, VII), and lists structured-JSON dependence as a deployment limit (Sec. VII). That premise is therefore load-bearing for transfer of the headline numbers, but it is not a hidden inconsistency: the interpretability contribution (rule activations, chain-score uncertainty flagging) is leakage-invariant by construction and does not require the metrics to be image-only. No stronger internal flaw (circular training, unacknowledged leakage, or unsupported claim of pure image superiority) is present.","agreement_with_reader":"agree"},"referee_report":{"model":"grok-4.5","summary":"The paper introduces GlaKG, a biomarker-centric heterogeneous knowledge graph for explainable glaucoma diagnosis and risk stratification from fundus images. It encodes six entity types, eight relation types, and 11 clinically grounded rules so that each prediction is accompanied by an explicit reasoning chain from biomarker attributes to activated rules (Eqs. 6–9). Image evidence (ResNet50 embeddings + Gradient Boosting) is combined with a min-max-normalized chain score via post-processing convex fusion (Eq. 12), with all fitting confined to the training split. On a public AI-annotated dataset the method reports F1 = 0.9953 for binary classification and 0.930 accuracy / 0.922 weighted F1 for four-class risk stratification, framed as upper bounds under clean structured biomarkers rather than leakage-free image-only performance. Ablations on fusion weight α, GNN baselines, feature-importance analysis, and a single false-negative case (CDR = 0.700, low chain score) support the interpretability claim.","tokens_in":13887,"tokens_out":1145,"duration_ms":9170,"significance":"If the framework holds, it supplies a concrete, clinician-auditable alternative to saliency-map XAI for glaucoma: every decision exposes which rules fired, at what strength, and how they aggregate, including low-score flagging of borderline cases. The pipeline hygiene (original split, train-only PCA/standardization/α selection, s_KG never used to train the image classifier) and open disclosure of annotation–label correlation are strengths that make the upper-bound framing credible. The modular design (image branch separable from rule anchors) is a practical contribution for incremental clinical integration. The work is therefore significant as an interpretability architecture even when headline metrics are understood as contingent on high-quality structured biomarkers.","major_comments":[{"comment":"Sec. IV-A/B and Tables III, VI, VII: the reported F1/accuracy rest on AI-generated biomarker fields that separate classes almost perfectly (100% rim thinning and ISNT violation in glaucoma, 0% pathological signs in normals; KG-only AUC = 1.000 at α = 1). The paper correctly frames these numbers as upper bounds and lists structured-JSON dependence as a limitation (Sec. VII), yet the abstract and contribution bullets still lead with the headline metrics. For the central claim to transfer, the manuscript should either (i) add an experiment with imperfect/noisy biomarkers (or automatic extraction) that degrades the chain score in a controlled way, or (ii) demote the numerical claims further so that the primary result is the leakage-invariant reasoning-chain audit trail rather than the upper-bound F1.","section":null},{"comment":"Eqs. 9–12 and Sec. V-C: the chain score CS is a fixed weighted sum of rule activations on the same attributes that define the labels on this dataset. Fusion with an independent image probability is a reasonable post-processing design, but the near-equal MDI contribution of KG vs. biomarker features (51.1% vs. 48.9%, Table V) is partly circular when both are derived from the same JSON fields. A clearer separation—e.g., reporting image-only vs. pure-rule performance on a second dataset without label-correlated annotations, or an ablation that removes the most label-correlated rules—would strengthen the claim that the KG supplies non-redundant clinical structure rather than re-encoding the annotation schema.","section":null}],"minor_comments":[{"comment":"Fig. 1 caption states α* = 0.5 while the text correctly notes that α* is selected by 5-fold CV; make the caption consistent with the selection procedure.","section":null},{"comment":"Table VII reports average rules/chain scores over all 689 diagnoses (including normals), which are lower than the TP subset means in Table VI; a short clarifying sentence already exists but could be moved earlier to avoid reader confusion.","section":null},{"comment":"The four-class AUC for the fused model (Table II) does not exceed the strongest image-only baseline; the text notes this but could briefly discuss why accuracy/weighted-F1 improve while AUC does not (minority-class operating-point effects).","section":null},{"comment":"Notation: ClinicalRule nodes are excluded from |Tv| = 6 yet appear in the total node count; a single sentence in Sec. III-A1 already explains this, but the schema figure caption could restate it for self-containment.","section":null},{"comment":"Minor typography: “▷ ◁k” in Eq. (6) and occasional missing spaces around α in the fusion equation; standard copy-editing will fix these.","section":null}],"recommendation":"major_revision","confidential_remarks":"The paper is unusually transparent about annotation–label correlation and pipeline hygiene; that honesty should be rewarded rather than punished. The main risk is over-reading the upper-bound metrics as general image-only performance. If the authors rebalance the abstract/contributions toward the reasoning-chain contribution and add even a modest noisy-biomarker or cross-dataset check, the manuscript would be a solid contribution for an XAI/medical-imaging venue. Scope fit is good for journals that value clinical interpretability over pure leaderboard gains."},"author_rebuttal":null,"desk_editor":{"model":"grok-4.5","letter":"The thing to know is that this is a careful methods paper, not a claim of pure image-only SOTA. They build a typed heterogeneous graph (6 entity types, 8 relations, 11 weighted clinical rules) and fuse a ResNet50+GB image score with a normalized reasoning-chain score at inference only. Every prediction comes with an explicit chain of which rules fired and at what strength. That package is the real contribution.\n\nWhat they do well: pipeline hygiene is explicit and correct. Original split, PCA and standardization fit on train only, rule thresholds from guidelines, alpha chosen by train CV, and s_KG never enters training of the image classifier. They openly state that the AI-annotated biomarkers are highly label-correlated (100% rim thinning/ISNT in glaucoma, 0% pathology in normals) and therefore present F1 0.9953 / risk Acc 0.930 as upper bounds under clean structured inputs, not as leakage-free image performance. Ablations on alpha, GNN baselines, MDI feature importance (~51/49 KG vs biomarker), and the single FN case (CDR exactly 0.7, chain score 9 vs ~16) are all useful. The chain actually flags its own uncertainty instead of failing silently. Citations are standard and appropriate; math is elementary but clean.\n\nSoft spots are real but already disclosed. The load-bearing premise is availability of structured biomarkers of this quality; without them the KG branch and the headline numbers do not transfer. That is listed as a deployment limit in the future-work section. Single public AI-annotated set, no multi-center or device-shift evaluation, and the GitHub pointer is not a full runnable artifact. Free parameters (alpha, strength weights, PCA dim, threshold) are ordinary. Circularity of the KG ranking power is moderate and acknowledged: at alpha=1 the AUC is 1.000 by construction of the annotations.\n\nThis is for people building explainable ophthalmic AI or clinical decision-support who care about rule-level audit trails more than leaderboard numbers. The central interpretability claim is leakage-invariant and holds up. I would send it to peer review; a serious referee can push on external biomarkers and code release without the paper collapsing. Worth engaging if that is your lane.","headline":"Solid, honest methods paper: a concrete fundus KG schema plus post-hoc fusion that actually ships rule-level audit trails, with metrics correctly framed as upper bounds under clean biomarkers.","tokens_in":14552,"tokens_out":551,"would_cite":false,"duration_ms":7954,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.5","headline":"GlaKG gives every glaucoma diagnosis an explicit chain of biomarker evidence and clinical rules.","keywords":["Glaucoma Diagnosis","Knowledge Graph","Explainable AI","Risk Stratification","Graph Neural Network","Fundus Imaging","Clinical Rules","Biomarkers"],"falsifier":"Apply the same fusion pipeline on a fundus cohort whose biomarkers are measured independently of the diagnosis labels (or extracted automatically from raw images) and test whether chain scores still rank cases and lift risk-stratification accuracy over image-only baselines.","tokens_in":14459,"feed_emoji":"👁️","tokens_out":877,"duration_ms":15126,"temperature":0.7,"pith_summary":"Most automated glaucoma systems score fundus images with deep networks but leave the decision opaque. This paper builds GlaKG, a knowledge graph that encodes structural biomarkers, eleven established clinical rules, and image features so that every prediction comes with a readable reasoning chain. A ResNet50 image score and a normalized rule-chain score are fused only at inference, with all fitting kept on the training split. On a public AI-annotated fundus set the method reaches near-ceiling binary F1 and strong four-class risk accuracy; the authors openly call these figures an upper bound because the annotations are highly label-correlated. The claim that matters for practice is not raw accuracy alone but that clinicians can see which rules fired, at what strength, and that low chain scores flag borderline cases instead of silent failures.","feed_headline":"Every glaucoma call gets an explicit clinical-rule chain","feed_subtitle":"A fundus knowledge graph fuses biomarkers and rules so clinicians can audit each decision.","key_machinery":"GlaKG’s reasoning-chain score: a weighted sum of activated clinical rules (CDR thresholds, ISNT violation, rim thinning, bayoneting, etc.) that is min-max normalized and fused with the image probability as p_final = (1−α)p_img + α s_KG, with α chosen by training-split cross-validation only.","core_discovery":"A biomarker-centric fundus knowledge graph with six entity types, eight relation types, and eleven clinically validated rules can produce, for every sample, an explicit reasoning chain from biomarker evidence to activated rules; post-processing fusion of ResNet50 probability with the normalized chain score then yields F1 0.9953 for binary glaucoma classification and 0.930 accuracy with 0.922 weighted F1 for four-class risk stratification on an AI-annotated public dataset, framed as an upper bound attainable with clean structured biomarkers rather than leakage-free image-only performance.","pith_inferences":["If automatic biomarker extractors from raw fundus images reach similar fidelity, the audit trail could transfer to clinics without pre-made JSON annotations.","The modular split between fixed rules and image features suggests the same pattern could encode rule sets for diabetic retinopathy or macular degeneration.","Low chain-score flagging could be wired into referral workflows so only uncertain cases escalate to specialists.","Cross-device and cross-dataset tests would show whether the fixed clinical thresholds remain stable when annotation quality varies."],"forward_implications":["Every automated glaucoma call can carry a clinician-readable audit trail of which biomarkers and rules drove it.","Borderline cases become visible as low chain scores rather than silent misclassifications.","Image encoders and clinical rule sets can be updated independently without end-to-end retraining.","KG-derived and biomarker features contribute near-equally (51.1% vs 48.9%), showing structured knowledge is complementary to visual cues.","The same schema supports four-class risk stratification with higher accuracy and weighted F1 than image-only baselines."],"fun_headline_variants":["GlaKG chains fundus biomarkers to clinical rules for every glaucoma call","Auditable glaucoma diagnosis via biomarker-centric fundus knowledge graph","Explicit rule chains turn glaucoma risk scores into traceable evidence","Fundus KG fuses six entities and eleven rules for explainable glaucoma","Biomarker-to-rule reasoning backs each glaucoma diagnosis and risk level"],"cache_read_input_tokens":128,"weakest_assumption_plain":"The method needs high-quality structured biomarker fields—like the AI annotations where pathological signs cleanly separate glaucoma from normal—so the fixed clinical rules can fire and produce a meaningful chain score.","fun_headline_variants_meta":{"raw":{"variants":["GlaKG chains fundus biomarkers to clinical rules for every glaucoma call","Auditable glaucoma diagnosis via biomarker-centric fundus knowledge graph","Explicit rule chains turn glaucoma risk scores into traceable evidence","Fundus KG fuses six entities and eleven rules for explainable glaucoma","Biomarker-to-rule reasoning backs each glaucoma diagnosis and risk level"]},"model":"grok-4.5","effort":"low","cost_usd":0.007062,"raw_usage":{"total_tokens":1779,"prompt_tokens":903,"num_sources_used":0,"completion_tokens":92,"cost_in_usd_ticks":70620000,"prompt_tokens_details":{"text_tokens":903,"audio_tokens":0,"image_tokens":0,"cached_tokens":0},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":784,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":903,"tokens_out":92,"duration_ms":6272,"temperature":1.0,"reasoning_tokens":784,"cache_read_input_tokens":0,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-07-11T15:24:38.020387+00:00","model_set":{"reader":"grok-4.5"},"falsifier":"Apply the same fusion pipeline on a fundus cohort whose biomarkers are measured independently of the diagnosis labels (or extracted automatically from raw images) and test whether chain scores still rank cases and lift risk-stratification accuracy over image-only baselines.","supporting_citations":[],"review_version":1}